bavituximab and durvalumab combination

Peregrine Pharma & AstraZeneca expand ongoing immuno-oncology deal

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, has expanded its ongoing cancer immunotherapy clinical collaboration with AstraZeneca, a global, innovation-driven biopharmaceutical business, to...
Read More

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!